Search hospitals > Wisconsin > Mukwonago
ProHealth D N Greenwald Center
Claim this profileMukwonago, Wisconsin 53149
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
154 reported clinical trials
1 medical researcher
Summary
ProHealth D N Greenwald Center is a medical facility located in Mukwonago, Wisconsin. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Adenocarcinoma and other specialties. ProHealth D N Greenwald Center is involved with conducting 154 clinical trials across 284 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at ProHealth D N Greenwald Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Renal Cell Carcinoma
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at ProHealth D N Greenwald Center?
ProHealth D N Greenwald Center is a medical facility located in Mukwonago, Wisconsin. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Adenocarcinoma and other specialties. ProHealth D N Greenwald Center is involved with conducting 154 clinical trials across 284 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.